CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 90 enrolled
Drug / intervention
Sulfonylureadrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02624817
NCT02624817Phase 4Completed
CompareCT.gov

Long-term Sulfonylurea Response and Glucose Control After Switching From Insulin in Children With Diabetes Due to KCNJ11 (KIR6.2) Mutations

Haukeland University Hospital·interventional·Posted Dec 8, 2015·Updated Oct 3, 2017

In Brief

A Phase 4 clinical trial evaluating Sulfonylurea for Permanent Neonatal Diabetes Mellitus. Completed, enrolled 90 participants across 1 site.

Detailed Summary

The purpose of this study is to investigate long term response of sulfonylurea and glucose control in children with diabetes due to mutations in KCNJ11 that have been switched from insulin injections to sulfonylurea tablets.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPermanent Neonatal Diabetes Mellitus
CountriesNorway
CollaboratorsUniversity of Bergen, University of Exeter, Royal Devon and Exeter NHS Foundation Trust, Institut National de la Santé Et de la Recherche Médicale, France, Hôpital Necker-Enfants Malades, University of Rome Tor Vergata

Timeline

Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedDec 8, 2015
Enrollment StartDec 1, 2015
Primary CompletionAug 1, 2016
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 10.6 years ago

Interventions

Sulfonylureadrug

See Arm description.